Related Experiment Video
Updated: Jul 11, 2025
06:59
A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
Published on: November 9, 2016
30.5K
Critical Challenges in Pluvicto Therapy: Incontinent and Anticoagulated Patients
1Carilion Clinic, Roanoke, Virginia jrcrowley@carilionclinic.org.
Journal of Nuclear Medicine Technology
|November 14, 2023
Summary
Molecular therapy for prostate cancer presents unique challenges. This guide addresses practical considerations for using Pluvicto (177Lu-vipivotide tetraxetan) in an outpatient setting.
Area of Science:
- Oncology
- Nuclear Medicine
- Radiopharmaceutical Therapy
Background:
- Molecular therapy is expanding, necessitating adaptive treatment protocols.
- Prostate cancer treatment is evolving with targeted therapies.
- Outpatient theranostic centers require specific protocols for novel agents.
Purpose of the Study:
- To highlight challenges in molecular prostate cancer therapy.
- To discuss practical aspects of using Pluvicto (177Lu-vipivotide tetraxetan).
- To present unique patient cases from an outpatient theranostic center.
Main Methods:
- Review of clinical protocols for Pluvicto (177Lu-vipivotide tetraxetan).
- Analysis of two unique patient treatment scenarios.
- Focus on outpatient management at a dedicated theranostic facility.
Main Results:
- Identification of specific challenges in Pluvicto administration.
- Description of patient management strategies for unique situations.
- Demonstration of successful outpatient targeted molecular therapy.
Conclusions:
- Therapeutic teams must anticipate and address challenges in molecular therapy.
- Pluvicto offers a novel approach to prostate cancer treatment.
- Effective protocols are crucial for successful outpatient theranostic care.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
01:30Venous Thrombosis IV: Nursing Management
14
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
14
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
10
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
10
01:26Cardiac Catheterization IV: Nursing Management
29
Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
29
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
01:27Pulmonary Embolism III: Nursing Management
15
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
15